Evidence map›Paper›PMID 33860966›Full record

ArticleJournal of magnetic resonance imaging : JMRI2021

Prospective Evaluation of Repeatability and Robustness of Radiomic Descriptors in Healthy Brain Tissue Regions In Vivo Across Systematic Variations in T2-Weighted Magnetic Resonance Imaging Acquisition Parameters.

Brendan Eck, Prathyush V Chirra, Avani Muchhala, Sophia Hall, Kaustav Bera, Pallavi Tiwari, Anant Madabhushi, Nicole Seiberlich, Satish E Viswanath

Abstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Brendan EckDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Prathyush V ChirraDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Avani MuchhalaDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Sophia HallDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Kaustav BeraDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Pallavi TiwariDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Anant MadabhushiDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Nicole SeiberlichDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Satish E ViswanathDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.ORCID 0000-0003-4550-8337

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
ConProject-002U2CDK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2017 to 2021
$21.0M
TRAINING PROGRAM IN MUSCULOSKELETAL RESEARCHT32AR007505 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI TRIOLO, RONALD J · 1986 to 2023
$6.3M
Pathology CoreU54CA254566 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GERSON, STANTON L., KIRENGA, BRUCE JAMES · 2020 to 2024
$5.0M
Improved Cardiac and Vascular MRI Using Parallel Imaging and Compressed SensingR01HL094557 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GRISWOLD, MARK, SEIBERLICH, NICOLE · 2010 to 2018
$4.5M
Computer-Assisted Histologic Evaluation of Cardiac Allograft RejectionR01HL151277 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MADABHUSHI, ANANT, MARGULIES, KENNETH BER · 2020 to 2023
$3.2M
Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC)R01CA249992 · NCI · EMORY UNIVERSITY · PI LEWIS, JAMES, MADABHUSHI, ANANT · 2021 to 2025
$3.2M
Computerized histologic image predictor of cancer outcomeR01CA202752 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI FELDMAN, MICHAEL D, GANESAN, SHRIDAR · 2016 to 2020
$3.1M
Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal CarcinomaR01CA220581 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI KOYFMAN, SHLOMO, LEWIS, JAMES · 2018 to 2023
$3.1M
Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung CancersR01CA216579 · NCI · EMORY UNIVERSITY · PI FU, PINGFU, LLOYD, MARK · 2018 to 2023
$3.1M
MR Fingerprinting and Computerized Decision Support for Prostate CancerR01CA208236 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GULANI, VIKAS, PONSKY, LEE EVAN · 2017 to 2022
$3.0M
Pathology Image Informatics Platform for visualization, analysis and managementU24CA199374 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GURCAN, METIN NAFI, MADABHUSHI, ANANT · 2015 to 2019
$2.9M
Biomedical Laboratory Research and Development, VA Office of Research and Development IBX004121ABiomedical Laboratory Research and Development, VA Office of Research and Development NCI R01CA249992-01A1BLRD VA I01 BX004121BLRD VA IK6 BX006185Case Western Reserve University the Wallace H. Coulter Foundation ProgramCongressionally Directed Medical Research Programs W81XWH-15-1-0558Congressionally Directed Medical Research Programs W81XWH-16-1-0329Congressionally Directed Medical Research Programs W81XWH-18-1-0404Congressionally Directed Medical Research Programs W81XWH-18-1-0440Congressionally Directed Medical Research Programs W81XWH-19-1-0668Congressionally Directed Medical Research Programs W81XWH-20-1-0595Congressionally Directed Medical Research Programs W81XWH-20-1-0851Dana Foundation David Mahoney Neuroimaging ProgramDivision of Chemical, Bioengineering, Environmental, and Transport Systems 1553441Johnson and Johnson WiSTEM2D AwardKidney Precision Medicine Project (KPMP) Glue GrantNCATS NIH HHS UL1TR0002548NCATS NIH HHS UL1 TR002548NCI NIH HHS 1U01CA239055-01NCI NIH HHS 1U01CA248226-01NCI NIH HHS 1U24CA199374-01NCI NIH HHS 1U54CA254566-01NCI NIH HHS R01 CA202752NCI NIH HHS R01CA202752-01A1NCI NIH HHS R01 CA208236NCI NIH HHS R01CA208236-01A1NCI NIH HHS R01 CA216579NCI NIH HHS R01CA216579-01A1NCI NIH HHS R01 CA220581NCI NIH HHS R01CA220581-01A1NCI NIH HHS R01CA249992-01A1NCI NIH HHS U01 CA239055NCI NIH HHS U01 CA248226NCI NIH HHS U24 CA199374NCI NIH HHS U54 CA254566NCRR NIH HHS 1C06RR12463-01NCRR NIH HHS C06 RR012463NHLBI NIH HHS 1R01HL151277-01A1NHLBI NIH HHS 2R01HL094557-06NHLBI NIH HHS R01 HL094557NHLBI NIH HHS R01 HL151277NHLBI NIH HHS R01 HL153034NIAMS NIH HHS 5T32AR007505-32NIAMS NIH HHS T32 AR007505NIBIB NIH HHS 1R43EB028736-01NIBIB NIH HHS 5T32EB00750912NIBIB NIH HHS R21 EB030208NIBIB NIH HHS R43 EB028736NIDDK NIH HHS U2C DK114886the Ohio Third Frontier Technology Validation FundV Foundation for Cancer Research Translational Research Award
6 · The paper itself

Abstract

backgroundRadiomic descriptors from magnetic resonance imaging (MRI) are promising for disease diagnosis and characterization but may be sensitive to differences in imaging parameters.

objectiveTo evaluate the repeatability and robustness of radiomic descriptors within healthy brain tissue regions on prospectively acquired MRI scans; in a test-retest setting, under controlled systematic variations of MRI acquisition parameters, and after postprocessing. STUDY TYPE: Prospective. SUBJECTS: Fifteen healthy participants. FIELD STRENGTH/SEQUENCE: A 3.0 T, axial T ASSESSMENT: One hundred and forty-six radiomic descriptors were extracted from a contiguous 2D region of white matter in each scan, before and after postprocessing. STATISTICAL TESTS: Repeatability was assessed in a test/retest setting and between manual and automated annotations for the reference scan. Robustness was evaluated between the reference scan and each group of variant scans (contrast weighting, resolution, and acceleration). Both repeatability and robustness were quantified as the proportion of radiomic descriptors that fell into distinct ranges of the concordance correlation coefficient (CCC): excellent (CCC > 0.85), good (0.7 ≤ CCC ≤ 0.85), moderate (0.5 ≤ CCC < 0.7), and poor (CCC < 0.5); for unprocessed and postprocessed scans separately.

resultsGood to excellent repeatability was observed for 52% of radiomic descriptors between test/retest scans and 48% of descriptors between automated vs. manual annotations, respectively. Contrast weighting (TR/TE) changes were associated with the largest proportion of highly robust radiomic descriptors (21%, after processing). Image resolution changes resulted in the largest proportion of poorly robust radiomic descriptors (97%, before postprocessing). Postprocessing of images with only resolution/acceleration differences resulted in 73% of radiomic descriptors showing poor robustness. DATA

conclusionsMany radiomic descriptors appear to be nonrobust across variations in MR contrast weighting, resolution, and acceleration, as well in test-retest settings, depending on feature formulation and postprocessing. EVIDENCE LEVEL: 2 TECHNICAL EFFICACY: Stage 2.

Indexed as

BrainMagnetic Resonance ImagingHumansProspective StudiesMRIradiomicsrepeatabilityreproducibilityrobustness

Identifiers

PMID33860966
PMCPMC8376104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.